当前位置: X-MOL 学术Mol. Ther. Nucl. Acids › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
MicroRNA-Based Prophylaxis in a Mouse Model of Cirrhosis and Liver Cancer
Molecular Therapy - Nucleic Acids ( IF 8.8 ) Pub Date : 2018-12-06 , DOI: 10.1016/j.omtn.2018.11.018
Elisa Callegari 1 , Marco Domenicali 2 , Ram Charan Shankaraiah 1 , Lucilla D'Abundo 1 , Paola Guerriero 1 , Ferdinando Giannone 2 , Maurizio Baldassarre 2 , Cristian Bassi 1 , Bahaeldin K Elamin 3 , Barbara Zagatti 1 , Manuela Ferracin 4 , Francesca Fornari 2 , Giuseppe Altavilla 5 , Stella Blandamura 5 , Enrico Maria Silini 6 , Laura Gramantieri 7 , Silvia Sabbioni 8 , Massimo Negrini 1
Affiliation  

Most hepatocellular carcinomas (HCCs) arise in the context of chronic liver disease and/or cirrhosis. Thus, chemoprevention in individuals at risk represents an important but yet unproven approach. In this study, we investigated the ability of microRNA (miRNA)-based molecules to prevent liver cancer development in a cirrhotic model. To this end, we developed a mouse model able to recapitulate the natural progression from fibrosis to HCC, and then we tested the prophylactic activity of an miRNA-based approach in the model. The experiments were carried out in the TG221 transgenic mouse, characterized by the overexpression of miR-221 in the liver and predisposed to the development of liver tumors. TG221 as well as wild-type mice were exposed to the hepatotoxin carbon tetrachloride (CCl4) to induce chronic liver damage. All mice developed liver cirrhosis, but only TG221 mice developed nodular lesions in 100% of cases within 6 months of age. The spectrum of lesions ranged from dysplastic foci to carcinomas. To investigate miRNA-based prophylactic approaches, anti-miR-221 oligonucleotides or miR-199a-3p mimics were administered to TG221 CCl4-treated mice. Compared to control animals, a significant reduction in number, size, and, most significantly, malignant phenotype of liver nodules was observed, thus demonstrating an important prophylactic action of miRNA-based molecules. In summary, in this article, we not only report a simple model of liver cancer in a cirrhotic background but also provide evidence for a potential miRNA-based approach to reduce the risk of HCC development.



中文翻译:

基于 MicroRNA 的小鼠肝硬化和肝癌模型的预防

大多数肝细胞癌(HCC)是在慢性肝病和/或肝硬化的背景下产生的。因此,对高危个体进行化学预防是一种重要但尚未得到证实的方法。在这项研究中,我们研究了基于 microRNA (miRNA) 的分子在肝硬化模型中预防肝癌发展的能力。为此,我们开发了一种能够重现从纤维化到 HCC 自然进展的小鼠模型,然后我们在该模型中测试了基于 miRNA 的方法的预防活性。该实验是在 TG221 转基因小鼠中进行的,该小鼠的特点是肝脏中 miR-221 过度表达,并且易于发生肝脏肿瘤。TG221 以及野生型小鼠暴露于肝毒素四氯化碳(CCl 4)以诱导慢性肝损伤。所有小鼠均出现肝硬化,但只有TG221小鼠在6月龄内100%出现结节性病变。病变范围从发育异常灶到癌。为了研究基于 miRNA 的预防方法,将抗 miR-221 寡核苷酸或 miR-199a-3p 模拟物给予 TG221 CCl 4处理的小鼠。与对照动物相比,观察到肝结节的数量、大小以及最显着的恶性表型显着减少,从而证明基于 miRNA 的分子具有重要的预防作用。总之,在本文中,我们不仅报告了肝硬化背景下肝癌的简单模型,而且还为基于 miRNA 的潜在方法降低 HCC 发展风险提供了证据。

更新日期:2018-12-06
down
wechat
bug